Capital Performance Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
16,250
+2,964
+22% +$431K 0.15% 69
2026
Q1
$1.92M Sell
13,286
-1,324
-9% -$201K 0.13% 75
2025
Q4
$2.09M Buy
14,610
+8,301
+132% +$1.22M 0.15% 69
2025
Q3
$969K Buy
6,309
+2,080
+49% +$325K 0.16% 73
2025
Q2
$674K Buy
4,229
+600
+17% +$97.9K 0.13% 81
2025
Q1
$618K Buy
3,629
+1,862
+105% +$312K 0.14% 77
2024
Q4
$296K Buy
1,767
+217
+14% +$37K 0.09% 96
2024
Q3
$268K Buy
+1,550
New +$263K 0.08% 87

Other funds holding PG

Capital Performance Advisors's PG Position: Q2 2026 in Review

Capital Performance Advisors increased its Procter & Gamble (PG) stake by 22% in Q2 2026, buying an estimated $431K and bringing the position to 16,250 shares worth $2.38M. The position accounts for 0.15% of the portfolio, ranked #69.

Capital Performance Advisors first reported a position in PG in Q3 2024 and has held it in 8 quarters since. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Capital Performance Advisors held 16,250 shares of Procter & Gamble worth $2.38M as of Q2 2026.
  • Capital Performance Advisors bought 2,964 Procter & Gamble shares in Q2 2026, an estimated $431K.
  • Procter & Gamble made up 0.15% of Capital Performance Advisors's portfolio in Q2 2026, its #69 holding.
  • Capital Performance Advisors first reported a position in Procter & Gamble in Q3 2024 and has held it in 8 quarters since.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.